Skip to Content
Merck
CN
  • Chloral hydrate sedation in radiology: retrospective audit of reduced dose.

Chloral hydrate sedation in radiology: retrospective audit of reduced dose.

Pediatric radiology (2012-01-17)
Jennifer Bracken, Ingrid Heaslip, Stephanie Ryan
ABSTRACT

Chloral hydrate (CH) is safe and effective for sedation of suitable children. The purpose of this study was to assess whether adequate sedation is achieved with reduced CH doses. We retrospectively recorded outpatient CH sedations over 1 year. We defined standard doses of CH as 50 mg/kg (infants) and 75 mg/kg (children >1 year). A reduced dose was defined as at least 20% lower than the standard dose. In total, 653 children received CH sedation (age, 1 month-3 years 10 months), 42% were given a reduced initial dose. Augmentation dose was required in 10.9% of all children, and in a higher proportion of children >1 year (15.7%) compared to infants (5.7%; P < 0.001). Sedation was successful in 96.7%, and more frequently successful in infants (98.3%) than children >1 year (95.3%; P = 0.03). A reduced initial dose had no negative effect on outcome (P = 0.19) or time to sedation. No significant complications were seen. We advocate sedation with reduced CH doses (40 mg/kg for infants; 60 mg/kg for children >1 year of age) for outpatient imaging procedures when the child is judged to be quiet or sleepy on arrival.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Chloral hydrate
Sigma-Aldrich
Chloral hydrate, crystallized, ≥98.0% (T)
Sigma-Aldrich
Chloral hydrate, ≥99%